Search Results
Prof. Gareth J Morgan | ASH 2017 | Novel oncogenes and tumor suppressor genes in NDMM
Sequencing the genome in myeloma: Pitfalls and opportunities in the clinic
Dr. Gareth Morgan Discusses Gene Expression Profiling for Smoldering Myeloma Patients
Structural variants in multiple myeloma: impact on outcomes & potential drug targets
Myeloma and the microenvironment
Update from IMS on Novel Technologies in Multiple Myeloma | Gareth Morgan, MD, PhD | IMS 2023
Multiple myeloma highlights at ASH 2017
ASH 2017 top picks: Phase III trials, antibody-drug conjugates and CAR T-cells
Myeloma XI: Gareth Morgan update
Dr. Morgan on the Future of Myeloma Treatment
Dr. Morgan on Idecabtagene Vicleucel in Multiple Myeloma
Why one size should not fit all for multiple myeloma
